EX-99.1 6 aeye-20250630xex99d1.htm EX-99.1

Exhibit 99.1

Ratification of the Grant of Certain Restricted Stock Units

WHEREAS, as set forth in greater detail below, the undersigned have been advised that upon a review of the Company’s records, it was determined that certain corporate actions, including certain purported rights issuances, may not have been effective and the Board and the Compensation Committee desire to ratify such corporate acts and rights issuances pursuant to Section 204 of the Delaware General Corporation Law (“DGCL”) (“Section 204”) and pursuant to the common law, as applicable.

WHEREAS, pursuant to Section 157(c) of the DGCL, a board of directors may adopt a resolution to delegate to a person or body, in addition to the board of directors, the authority to enter into 1 or more transactions to issue rights or options, provided that such resolution fixes certain parameters for such delegation.

WHEREAS, on October 29, 2020, the Board appointed the Compensation Committee as the “Committee” under the AudioEye, Inc. 2020 Equity Incentive Plan (the “2020 Plan”).

WHEREAS, on December 5, 2020, the Compensation Committee, as the Committee under the 2020 Plan, delegated (the “Grant Committee Delegation”) to a committee comprised solely of David Moradi, the Chief Executive Officer of the Company (the “Grant Committee”), the authority to determine, grant and administer awards pursuant to the 2020 Plan to employees of the Company whose annual base salary is $200,000 or less and who are not ‘executive officers’ of the Company (as defined by Rule 3b-7 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), ‘officers’ of the Company (as defined in Rule 16a-1 under the Exchange Act), or members of the Grant Committee through the date of the 2022 Annual Meeting of Stockholders of the Company.

WHEREAS, on January 14, 2021, the Compensation Committee, as the Committee under the 2020 Plan, delegated to the Grant Committee the authority to determine performance goals with respect to performance-based equity awards, whether previously granted or to be granted, to employees or consultants under all equity incentive plans of the Company and to determine whether any such performance goals have been met, other than equity awards granted to executive officers or directors.

WHEREAS, the 2022 Annual Meeting of Stockholders of the Company was held on May 20, 2022, and between June 1, 2022 and April 9, 2025, the Company, acting via the Grant Committee, (i) awarded grants of restricted stock units (including both time-based and performance-based, collectively “RSUs”) in the amounts listed on Exhibit A attached hereto and (ii) made certain determinations regarding previously-granted RSUs to vest a portion thereof in excess of amounts earned or in advance of the scheduled vesting date (all of such grants in (i) and (ii), the “Grants”).

WHEREAS, Section 204 of the DGCL defines (i) a “defective corporate act” as any act or transaction purportedly taken on behalf of a corporation that is, and at the time such act was purportedly taken would have been, within the power of a corporation, but is void or voidable due to a failure of authorization, and (ii) “putative stock” as the shares of any class or series of capital stock of a corporation (including shares issued upon exercise of options, rights, warrants or other securities convertible into shares of capital stock of the corporation, or interests with respect thereto that were created or issued pursuant to a defective corporate act) that, but for any failure of authorization, would constitute valid stock.

WHEREAS, pursuant to Section 204 of the DGCL, no defective corporate act or putative stock shall be void or voidable solely as a result of a failure of authorization, if ratified pursuant to Section 204 of the DGCL.

WHEREAS, the Board and the Compensation Committee have determined that, while the resolutions of the Compensation Committee, acting as the Committee under the 2020 Plan, effecting the Grant Committee Delegation specified, in compliance with the requirements of Section 157(c) of the DGCL, a time period during which such rights or options could be awarded, the Grants are defective corporate acts because the Grants occurred outside of the time period specified in those resolutions and/or because certain determinations made by the Grant Committee related to the vesting of RSUs were not pursuant to the terms of the RSUs as originally granted and so were outside the Grant Committee’s delegated authority; further, the Grant Committee Delegation did not include certain parameters that


were required following amendments to Section 157(c) of the DGCL in 2022, which resulted in Grants made after the effectiveness of such amendments being defective corporate acts.

WHEREAS, the Board and Compensation Committee have determined that it is advisable and in the best interests of the Company and its stockholders to approve and ratify the Grants, the issuance of shares of common stock upon settlement of any RSUs granted thereunder and the related putative stock in all respects.

WHEREAS, pursuant to Section 204(c) of the DGCL, the Company is not required to submit the ratification to the stockholders for approval.

WHEREAS, pursuant to Section 204(g) of the DGCL, the Company is required to give prompt notice of the ratification to all holders of valid stock, as of a date within 60 days of the adoption of these resolutions, which notice will be deemed to have been given if disclosed in a document publicly filed by the Company with the Securities and Exchange Commission (the “SEC”) pursuant to §13, §14 or §15(d) of the Exchange Act (such notice, the “Notice”).

NOW, THEREFORE BE IT RESOLVED, that each of the individual grants and determinations comprising the Grants, as listed on Exhibit A, are the defective corporate acts to be ratified.

FURTHER RESOLVED, that the nature of the failure of proper authorization in respect of the Grants is the failure of the Grant Committee to exercise its authority within the specified time period during which such rights or options may be issued in accordance with the Board’s and Compensation Committee’s delegation of authority to the Grant Committee and Section 157(c) of the DGCL, or were outside the terms of the RSUs as originally granted and so were outside of the scope of the Grant Committee’s delegated authority, and, with respect to certain Grants, the failure of proper delegation of authority following the 2022 amendments of Section 157(c) of the DGCL.

FURTHER RESOLVED, that pursuant to Section 204 of the DGCL, the Board and the Compensation Committee, acting as the Committee under the 2020 Plan, hereby authorize, ratify and approve the Grants as specified in Exhibit A, as of the original grant or determination dates as applicable, and the issuance of shares of putative stock as of the original time of settlement of any RSUs granted thereunder, and such shares of putative stock shall be considered validly issued, fully paid and non-assessable at the time such shares were originally issued.

FURTHER RESOLVED, that the appropriate officers of the Company are hereby authorized to file the Notice pursuant the Exchange Act.

General Resolutions

FURTHER RESOLVED, that the officers of the Company (the “Authorized Officers”), be, and each of them hereby is, authorized, empowered and directed, in the name and on behalf of the Company, to take or cause to be taken any and all such further actions, to execute and deliver or cause to be executed and delivered all such other documents, certificates, instruments and agreements, and to make such filings, with the SEC or otherwise, in the name and on behalf of the Company, to incur and pay all such fees and expenses and to engage in such acts as they shall in their judgment determine to be necessary, desirable or advisable in order to carry out fully the intent and purposes of the foregoing resolutions and the execution by the Authorized Officers of any such documents, certificates, instruments or agreements or the payment of any such fees and expenses or the doing by them of any act in connection with the foregoing matters shall conclusively establish their authority therefor and the approval of the documents, certificates, instruments and agreements so executed, the expenses so paid, the filings so made and the actions so taken; and be it

FURTHER RESOLVED, that any and all actions heretofore taken by any officer, representative or director of the Company in connection with any matter referred to or contemplated in any of the foregoing resolutions are hereby approved, ratified and confirmed in all respects as the act and deed of the Company.


Exhibit A

List of Grants

RSU: Restricted Stock Unit (may be time-based or performance-based)

Grant Date

Number of RSUs

June 1, 2022

2231

June 1, 2022

892

June 1, 2022

2431

June 1, 2022

587

June 1, 2022

458

June 1, 2022

589

June 1, 2022

542

June 1, 2022

2333

June 1, 2022

200

June 1, 2022

3000

June 1, 2022

1500

June 1, 2022

2675

June 1, 2022

5416

June 1, 2022

469

June 1, 2022

542

June 1, 2022

1279

June 1, 2022

638

June 1, 2022

792

June 1, 2022

3141

June 1, 2022

2789

June 1, 2022

875

June 1, 2022

445

June 1, 2022

268

June 1, 2022

428

June 1, 2022

488

June 1, 2022

667

June 1, 2022

542

June 1, 2022

458

June 1, 2022

2783

June 1, 2022

542

June 1, 2022

4375

June 1, 2022

763

June 1, 2022

200


June 1, 2022

2500

June 1, 2022

2360

June 1, 2022

243

June 1, 2022

2243

June 1, 2022

1863

June 1, 2022

1667

June 1, 2022

200

June 1, 2022

200

June 1, 2022

1978

June 1, 2022

708

June 1, 2022

1917

June 1, 2022

200

June 1, 2022

2168

June 1, 2022

1333

June 1, 2022

1058

June 1, 2022

1792

June 1, 2022

708

June 1, 2022

4499

June 1, 2022

3000

June 1, 2022

1366

June 1, 2022

237

June 1, 2022

1700

June 1, 2022

4300

June 1, 2022

272

June 1, 2022

542

June 1, 2022

583

June 1, 2022

633

June 1, 2022

253

June 1, 2022

398

June 1, 2022

2424

June 1, 2022

1171

June 1, 2022

200

June 1, 2022

1750

June 1, 2022

2500

June 1, 2022

617

June 1, 2022

471

June 1, 2022

567

June 1, 2022

372

June 1, 2022

2622

June 1, 2022

2333


June 1, 2022

1000

June 1, 2022

200

June 1, 2022

688

June 1, 2022

575

June 1, 2022

583

June 1, 2022

2634

June 1, 2022

1947

June 1, 2022

583

June 1, 2022

1888

June 1, 2022

708

June 1, 2022

583

June 1, 2022

917

July 8, 2022

217

September 6, 2022

3000

September 6, 2022

3090

September 6, 2022

1125

September 6, 2022

2667

September 6, 2022

416

September 6, 2022

583

September 6, 2022

2500

September 6, 2022

3267

September 6, 2022

916

January 8, 2023

1458

January 8, 2023

792

January 8, 2023

792

January 8, 2023

583

January 8, 2023

625

January 8, 2023

10000

March 16, 2023

500

March 16, 2023

542

March 16, 2023

583

March 16, 2023

667

March 16, 2023

688

March 16, 2023

2000

March 16, 2023

1167

March 16, 2023

2667

March 16, 2023

3333

March 16, 2023

5000

March 16, 2023

7500

April 17, 2023

5000

April 10, 2023

2750

April 26, 2023

6600


June 1, 2023

6000

May 1, 2023

6900

April 26, 2023

1916

August 4, 2023

1083

August 4, 2023

1083

August 4, 2023

750

August 4, 2023

1500

August 4, 2023

750

August 4, 2023

1500

August 4, 2023

1833

August 4, 2023

2833

August 4, 2023

3083

August 4, 2023

4340

November 17, 2023

2250

November 17, 2023

5866

November 17, 2023

1083

November 17, 2023

1083

November 17, 2023

2083

November 17, 2023

2166

November 17, 2023

2333

November 17, 2023

750

January 18, 2024

2000

January 18, 2024

3000

January 18, 2024

3000

January 18, 2024

3000

January 18, 2024

4000

January 18, 2024

5000

January 18, 2024

2000

January 18, 2024

5000

January 18, 2024

1833

January 18, 2024

1083

January 18, 2024

542

January 18, 2024

625

January 18, 2024

728

January 18, 2024

9333

January 18, 2024

1083

January 18, 2024

5000

April 18, 2024

6993

June 25, 2024

667

June 25, 2024

542

June 25, 2024

2166

June 25, 2024

625

June 25, 2024

139


June 25, 2024

153

June 25, 2024

153

June 25, 2024

666

June 25, 2024

165

September 6, 2024

170

September 6, 2024

153

September 6, 2024

467

September 6, 2024

2000

September 6, 2024

181

September 6, 2024

125

September 6, 2024

236

September 6, 2024

583

September 6, 2024

330

September 6, 2024

288

September 6, 2024

376

September 6, 2024

389

September 6, 2024

848

September 6, 2024

314

December 16, 2024

171

December 16, 2024

615

December 16, 2024

525

December 16, 2024

444

December 16, 2024

460

December 16, 2024

556

December 16, 2024

264

December 16, 2024

450

December 16, 2024

208

December 16, 2024

106

December 16, 2024

117

December 16, 2024

188

December 16, 2024

211

December 16, 2024

1377

April 9, 2025

577

April 9, 2025

278

April 9, 2025

264

April 9, 2025

222

April 9, 2025

181

April 9, 2025

778

April 9, 2025

839

April 9, 2025

1625

April 9, 2025

194

April 9, 2025

675

April 9, 2025

194


April 9, 2025

319

April 9, 2025

430

April 9, 2025

5000

April 9, 2025

3811

Determination Date

Number of RSUs

April 18, 2023

4858

November 29, 2023

5000

August 29, 2024

90

August 29, 2024

1846

November 14, 2024

1875

December 16, 2024

286

December 16, 2024

249

March 13, 2025

521

March 13, 2025

844

May 21, 2025

165